Your browser doesn't support javascript.
loading
Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability.
Harms, Mirja; Fabech Hansson, Rikke; Gilg, Andrea; Almeida-Hernández, Yasser; Löffler, Jessica; Rodríguez-Alfonso, Armando; Habib, Monica M W; Albers, Dan; Ahmed, Nermin S; Abadi, Ashraf H; Winter, Gordon; Rasche, Volker; Beer, Ambros J; Weidinger, Gilbert; Preising, Nico; Ständker, Ludger; Wiese, Sebastian; Sanchez-Garcia, Elsa; Zelikin, Alexander N; Münch, Jan.
Afiliação
  • Harms M; Institute of Molecular Virology, Ulm University Medical Center, Ulm 89081, Germany.
  • Fabech Hansson R; Department of Chemistry and iNANO Interdisciplinary Nanoscience Centre, Aarhus University, Aarhus 8000, Denmark.
  • Gilg A; Institute of Molecular Virology, Ulm University Medical Center, Ulm 89081, Germany.
  • Almeida-Hernández Y; Department of Biochemical and Chemical Engineering, Computational Bioengineering, Emil-Figge Str. 66, Dortmund 44227, Germany.
  • Löffler J; Department of Nuclear Medicine, Ulm University Medical Center, Ulm 89081, Germany.
  • Rodríguez-Alfonso A; Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm 89081, Germany.
  • Habib MMW; Core Unit Mass Spectrometry and Proteomics, Ulm University Medical Center, Ulm 89081, Germany.
  • Albers D; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
  • Ahmed NS; Pharmaceutical Chemistry Department, School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation, Cairo 11865, Egypt.
  • Abadi AH; Institute of Molecular Virology, Ulm University Medical Center, Ulm 89081, Germany.
  • Winter G; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
  • Rasche V; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
  • Beer AJ; Department of Nuclear Medicine, Ulm University Medical Center, Ulm 89081, Germany.
  • Weidinger G; Experimental Cardiovascular Imaging (ExCaVI), Ulm University Medical Center, Ulm 89081, Germany.
  • Preising N; Department of Nuclear Medicine, Ulm University Medical Center, Ulm 89081, Germany.
  • Ständker L; Institute of Biochemistry and Molecular Biology, Ulm University, Ulm 89081, Germany.
  • Wiese S; Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm 89081, Germany.
  • Sanchez-Garcia E; Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm 89081, Germany.
  • Zelikin AN; Core Unit Mass Spectrometry and Proteomics, Ulm University Medical Center, Ulm 89081, Germany.
  • Münch J; Department of Biochemical and Chemical Engineering, Computational Bioengineering, Emil-Figge Str. 66, Dortmund 44227, Germany.
J Med Chem ; 66(22): 15189-15204, 2023 11 23.
Article em En | MEDLINE | ID: mdl-37940118
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Limite: Humans Idioma: En Revista: J Med Chem Assunto da revista: QUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Limite: Humans Idioma: En Revista: J Med Chem Assunto da revista: QUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha